Loading...
OTCM
CHBOF
, Last price  
USD
Name

China Bozza Development Holdings Ltd

Chart & performance

D1W1MN
OTCM:CHBOF chart
P/E
—
P/S
—
EPS
0.28
Vol. 1Y
—
Shs. 5Y
55.44%
Rev. 5Y
70.94%
Div Yld LY
—
Div Yld TTM
—
Revenues
97m
-0.09%
106,928,000144,164,000146,003,000202,232,000184,804,00092,438,00066,956,00026,837,00010,132,00020,114,00085,572,00051,359,00054,254,0006,666,0006,756,00058,717,00047,606,00097,390,38597,304,743
Net income
24m
-1.24%
13,492,00017,393,00015,702,00023,089,000411,000-20,037,000-19,632,000-90,322,000-59,854,000-52,452,000-7,739,000-65,251,000-340,484,000-268,541,000-18,900,000-10,800,000200,013,00024,517,35324,212,294
CFO
37m
+29.69%
23,956,0008,288,00010,369,00021,006,000-1,187,0003,515,000-26,390,000-41,232,000-24,394,000-50,369,0009,211,000-4,586,000-9,728,000-5,584,000-466,00023,438,00028,858,00037,426,450

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

China Health Technology Group Holding Co., Ltd. functions as an investment firm, concentrating its efforts on forestry management. Its activities include the cultivation, felling, and commercialization of timber goods. The organization was established on October 8, 2009, and maintains its principal place of business in Shenzhen, China.

Key people

Phillip Fei
Chairman of the Board, Executive Director · since 2019
Jiamin Feng
Executive Director · since 2019
Wenjun Li
Chief Executive Officer, Executive Director · since 2019
Weihua Long
Executive Director · since 2013
Wei Lu
Executive Director · since 2019
Yue Wang
Executive Director · since 2019
Hiu Tung Wong
Executive Director · since 2019
Man Kit Leung
Joint Company Secretary, Assistant to Chairman, Project Director · since 2014
Guoxin Liang
Independent Non-Executive Director · since 2013
Zhaoxiang Liu
Independent Non-Executive Director · since 2014
Guangmei Tian
Independent Non-Executive Director · since 2013
URL
http://www.chinacaflc.com/
IPO date
Oct 08, 2009
Employees
16
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122025‑062024‑062023‑062022‑062020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT